Cohen, Michael, M.D.

We have been interested in the pathobiology of prostate cancer for two decades. Our initial work, starting in the early-mid 1990’s, focused on understanding the mechanisms of resistance to receptor-ligand-mediated apoptosis. From that work we began investigating the role of androgen/androgen receptor in cell death. Our current research is to develop new therapeutic approaches for (advanced) castration resistant prostate cancer (CRPC).